E-Learning

On Monday, Phio Pharmaceuticals Corp. (NASDAQ:PHIO) stock skyrocketed with a strong session volume of 201.04 million, compared to the average volume of 362.72k, according to data from Benzinga Pro. Phio reported pathologic responses for patients enrolled in the 2nd cohort, which includes two patients with a complete response or 100% tumor clearance. Phio’s ongoing Phase 1b clinical study is designed to evaluate the safety and tolerability of neoadjuvant use of intratumoral PH-762 in Stages 1, 2

U.S. Steel shares jumped Monday on a report that Cleveland-Cliffs is teaming up with rival Nucor for a potential bid for the company, whose $14.1 billion buyout by Nippon Steel was recently blocked by President Joe Biden.

(Bloomberg) -- Traders are bracing for one of the most volatile earnings periods in stock market history.Most Read from BloombergThese Homes Withstood the LA Fires. Architects Explain WhyA Blueprint for Better Bike LanesWhat Robotaxis Brought San FranciscoAmbitious High-Speed Rail Plans Advance in the Baltic RegionAt least that’s what they are positioning for two days before big banks kick off the reporting cycle in the US. Options traders expect individual stocks in the S&P 500 Index to move 4.

(Bloomberg) -- Dealmakers, who were gearing up for a busy year of initial public offerings, have already been confronted by a formidable challenge: rising Treasury yields that could deflate enthusiasm for new listings.Most Read from BloombergThese Homes Withstood the LA Fires. Architects Explain WhyA Blueprint for Better Bike LanesWhat Robotaxis Brought San FranciscoAmbitious High-Speed Rail Plans Advance in the Baltic RegionUS IPO volume in 2025 was expected to return to prepandemic levels afte

U.S. equities were mixed at midday, with the Nasdaq losing more than 1% on worries about future Federal Reserve interest-rate cuts.

JPMorgan Chase is scheduled to report earnings before the opening bell Wednesday, kicking off a stretch of earnings reports as America's largest financial institutions wrap up their 2024s.

Moderna shares plunged Monday after the company cut its 2025 revenue forecast by $1 billion.

Macy's said its fourth-quarter results would be pulled down by poor performance by some of its stores.

Apparel retailer Abercrombie & Fitch lifted its end-of-year outlook today, but its shares were down nearly 20% in recent trading.

As the Biden administration heads into its final week, AI industry players are cozying up to the incoming president, likely in hopes that he’ll nix the restrictions.